On October 22, 2020, Helix Acquisition Corp. consummated its initial public offering of 11,500,000 Class A ordinary shares, par value $0.0001 per share including the issuance of 1,500,000 shares of Class A Ordinary Shares as a result of the underwriter's exercise in full of its over-allotment option. The Class A Ordinary Shares were sold at a price of $10.00 per share, generating gross proceeds to the Company of $115,000,000. On October 19, 2020, in connection with the IPO, Dr. Nancy Chang, Mr. Will Lewis and Mr. John Schmid were appointed to the board of directors of the Helix Acquisition Corp. The Directors are independent directors. Effective October 19, 2020, Dr. Chang, Mr. Lewis and Mr. Schmid were also appointed to the Board’s Audit Committee, with Mr. Schmid serving as chair of the Audit Committee, Compensation Committee, with Mr. Lewis serving as chair of the Compensation Committee and Nominating and Corporate Governance Committee, with Dr. Chang serving as chair of the Nominating and Corporate Governance Committee. Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consisting of Dr. Chang and Mr. Lewis, will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, Class II, consisting of Mr. Schmid and will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consisting of Ms. Chen, the Company’s Chief Executive Officer and Chairman of the Board, will expire at the Company’s third annual meeting of stockholders.